AstraZeneca Shares Hit 10-week High
AstraZeneca shares increased to 12806.00 GBp, the highest since July 2026. Over the past 4 weeks, AstraZeneca gained 5.37%, and in the last 12 months, it increased 1.86%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bank of America lifts Soitec on margin outlook
Bank of America analysts raised Soitec to buy from neutral, saying photonics should significantly expand the French semiconductor-materials maker's gross margin over the coming years. They see gross margin rising to 29% in fiscal 2027, 39% in fiscal 2028 and 44% in fiscal 2029.
Citi sees Novo Nordisk sales slightly above consensus
Citi said Novo Nordisk's third-quarter sales could come in 1% above consensus, helped by a strong Wegovy pill launch in the U.K. The bank cut its target price to 296 kroner from 310 kroner and kept a neutral rating.
Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%
U.S. stocks slipped by midday Wednesday as a sharp selloff in industrials weighed on the Dow Jones and small caps, while healthcare provided a rare pocket of strength. The S&P 500 fell 0.4% to 7,788, while the Dow Jones Industrial Average dropped 0.9%, or 465 points, to 51,056. The Dow was weighed down by Caterpillar I
AstraZeneca Stock Price Hits 7-week High
AstraZeneca shares increased to 12480.00 GBp, the highest since July 2026. Over the past 4 weeks, AstraZeneca gained 3.26%, and in the last 12 months, it increased 10.08%.
Transcript: AstraZeneca Q2 2026 Earnings Conference Call
On Monday, AstraZeneca (NASDAQ: AZN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary AstraZeneca reported a 6% growth in total revenue for the fi